Algorae Pharmaceuticals Limited (ASX:1AI)
Australia · Delayed Price · Currency is AUD 0.0120
0.00 (0.00%)
Apr 17, 2026, 4:10 PM AEST
Algorae Pharmaceuticals Market Cap
Algorae Pharmaceuticals has a market cap or net worth of 24.28 million as of April 17, 2026. Its market cap has increased by 105.53% in one year.
Market Cap
24.28M
Enterprise Value
22.39M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.01
Market Cap Chart
Since September 1, 2004, Algorae Pharmaceuticals's market cap has increased from 12.17M to 24.28M, an increase of 99.51%. That is a compound annual growth rate of 3.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 24.28M | 2.68% |
| Dec 31, 2025 | 23.64M | 133.52% |
| Dec 30, 2024 | 10.12M | -39.06% |
| Dec 29, 2023 | 16.61M | 7.70% |
| Dec 30, 2022 | 15.42M | 185.23% |
| Dec 30, 2021 | 5.41M | -32.40% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Imugene | 53.55M |
| Entropy Neurodynamics | 46.90M |
| Proteomics International Laboratories | 42.12M |
| EZZ Life Science Holdings | 37.89M |
| NeuroScientific Biopharmaceuticals | 34.92M |
| Avecho Biotechnology | 33.06M |
| Argenica Therapeutics | 20.55M |
| Noxopharm | 19.05M |